Current Edition

Respiratory Drug Development – Perspective from Spray and Aerosol Characterisation Expert

Dino Farina, Founder and CEO of Proveris Scientific
IPI speaks with Dino Farina, Founder and CEO of Proveris, on how they have helped customers to develop optimally performing orally inhaled and nasal drug products (OINDPs) for patients around the world.
[gview file=”https://www.ipimediaworld.com/wp-content/uploads/2021/04/Respiratory-Drug-Development-–-Perspective.pdf”]